Microbiome Remodeling
Microbiome Remodeling - Related Videos
02:54
Nucleosome Remodeling
0 Views •
2020
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure. Nucleosome remodeling complex Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
01:22
Microbiome of the Eye
0 Views •
2026
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
10:51
Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device
0 Views •
Cited by 68 •
2016
We describe an in vitro protocol to co-culture gut microbiome and intestinal villi for an extended period using a human gut-on-a-chip microphysiological system.
07:31
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
0 Views •
Cited by 26 •
2016
A rat model of abdominal aortic constriction that induces cardiac hypertrophy and remodeling is described. An efficient, highly-reproducible, and minimally-invasive method is used to provide a simple yet useful platform for research in myocardial hypertrophy and dysfunction.
10:14
Biochemical Assays for Analyzing Activities of ATP-dependent Chromatin Remodeling Enzymes
0 Views •
Cited by 4 •
2014
Here we describe biochemical assays that can be used to characterize ATP-dependent chromatin remodeling enzymes for their abilities to 1) catalyze ATP-dependent nucleosome sliding, 2) engage with nucleosome substrates, and 3) hydrolyze ATP in a nucleosome- or DNA-dependent manner.
FAQs
Changes in community composition, abundance, and function can alter which microbial metabolites are produced and how strongly they affect the host. These downstream signals may influence barrier function and immune signaling, so a taxonomic shift matters clinically only when it changes microbial activity or host responses. This is why remodeling studies examine both community structure and function.
These influences can change nutrient availability and the ecological pressures experienced by resident microorganisms. As conditions shift, some populations may increase, decrease, or alter their activity, producing a different community balance and functional output. Comparing these pressures helps researchers distinguish remodeling driven by an intervention from changes associated with disease-related environments.
A microbiome change may be biologically interesting without producing a reliable clinical benefit. Medical strategies therefore need to determine whether the altered community and its functions persist, whether the change is safe, and whether it suits the individual patient. These criteria help separate potentially useful remodeling from temporary or poorly tolerated shifts.
The source identifies diet, antibiotics, probiotics, and fecal microbiota transplantation as approaches that can alter microbial communities. They differ in how they change nutrient availability, microbial abundance, or community composition. Researchers compare these options according to the intended biological effect, safety considerations, expected durability, and the need for a patient-specific strategy.
Investigation is relevant when microbial communities may contribute to infections, inflammatory disorders, metabolic conditions, or other disease-associated changes. Researchers examine whether altered microbial functions, metabolites, barrier effects, or immune signals are connected with the condition. This work can support strategies designed to influence disease-related microbial activity rather than focusing only on microorganism counts.
Evaluation can consider changes in community composition, abundance, and function, along with effects on microbial metabolites, host barrier function, and immune signaling. These outcomes show whether an intervention produced more than a superficial community shift. In medicine, they also help assess whether the change is durable, safe, and relevant to the patient’s condition.